Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effectiveness of a video-based intervention in improving skin cancer risk awareness and preventative behaviors among a diverse population of solid organ transplant recipients.
Journal: JAAD international
Published: November 11, 2024
A severe case of reactive infectious mucocutaneous eruption associated with two possible triggers: Coronavirus and group A streptococcus.
Journal: Pediatric dermatology
Published: December 19, 2023
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
Journal: The British journal of dermatology
Published: December 15, 2023
Cutaneous adverse effects induced by tebentafusp in patients with metastatic uveal melanoma: a case series and treatment insights.
Journal: Clinical and experimental dermatology
Published: November 02, 2023
Field Cancerization in Dermatology: Updates on Treatment Considerations and Emerging Therapies.
Journal: Cutis
Published: July 20, 2022
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
Journal: JAMA dermatology
Published: March 02, 2022
Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 18, 2019
Chronic nonmelanoma skin cancers and health-related impairment: A case-control study.
Journal: Journal of the American Academy of Dermatology
Published: September 06, 2017
Update on advanced melanoma treatments: small molecule targeted therapy, immunotherapy, and future combination therapies.
Journal: Wiener medizinische Wochenschrift (1946)
Published: July 17, 2016
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.
Journal: Oncotarget
Published: August 30, 2015
Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies.
Journal: AIMS public health
Published: February 21, 2015
Last Updated: 09/26/2026